Vanda Pharmaceuticals: Q3 Earnings Insights

Vanda Pharmaceuticals VNDA reported its Q3 earnings results on Wednesday, November 3, 2021 at 04:00 PM.

Here's what investors need to know about the announcement.

Vanda Pharmaceuticals their estimated earnings by 12.5%, reporting an EPS of $0.14 versus an estimate of $0.16, which surprised analysts.

Revenue was up $9,787,000 from the same period last year.

Last quarter the company beat on EPS by $0.03, which was followed by a 8.5% drop in the share price the next day.

Here's a look at Vanda Pharmaceuticals's past performance:

Quarter	Q2 2021	Q1 2021	Q4 2020	Q3 2020
EPS Estimate	0.14	0.15	0.14	0.09
EPS Actual	0.17	0.15	0.15	0.11
Revenue Estimate	69.75M	68.50M	64.00M	63.95M
Revenue Actual	67.90M	62.67M	67.65M	60.31M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

Earnings Calendar